Skip to main content
Clinical Trials/CTRI/2025/04/085259
CTRI/2025/04/085259Not yet recruitingPhase 2

Efficacy of Sugammadex versus Neostigmine on post operative nausea and vomiting after general anaesthesia in adult patients: a randomised control trial

DrRatulbir Goyal1 site in 1 country136 target enrollmentStarted: April 30, 2025Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
136
Locations
1
Primary Endpoint
To Compare the Incidence of PONV between both the drugs within the first 24 hours of Post Operative period

Study Overview

Brief Summary

NEOSTIGMINE AND GLYCOPYROLATE IN COMBINATION IS THE COMMON REVERSAL AGENT THAT IS USED . SUGAMMADEX CAN OFFER QUICKER AND BETTER RECOVERY AND DECREASED INCIDENCE OF POST OPERATIVE NAUSEA AND VOMITTING

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant, Investigator and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • All ASA-1 and ASA-2 patients not coming under exclusion criteria.

Exclusion Criteria

  • Pregnancy and Breastfeeding Mothers Neuromuscular Disorders Significant Hepatic And Renal Impairement.

Outcomes

Primary Outcomes

To Compare the Incidence of PONV between both the drugs within the first 24 hours of Post Operative period

Time Frame: 24 hours

Secondary Outcomes

  • To Compare the Clinical Parametres of Recovery(1 HOUR)

Investigators

Sponsor
DrRatulbir Goyal
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Ratulbir Goyal

Kalinga Institute of Medical Sciences

Study Sites (1)

Loading locations...

Similar Trials

To compare the incidence of post operative... | Clinical Trial